Japan Antacids Market Size, Share, and COVID-19 Impact Analysis, By Type (Tablet, Liquid, and Others), By End Use (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and Japan Antacids Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareJapan Antacids Market Insights Forecasts to 2035
- The Japan Antacids Market Size Was Estimated at USD 344.8 Million in 2024
- The Market Size is Expected to Grow at a CAGR of Around 5.44% from 2025 to 2035
- The Japan Antacids Market Size is Expected to Reach USD 617.4 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the Japan antacids market is anticipated to reach USD 617.4 million by 2035, growing at a CAGR of 5.44% from 2025 to 2035. The Japan antacids market is driven by various factors, including changing dietary habits, a rise in the aging population, an increased incidence of acid reflux and gastritis, rising awareness about digestive health, and a rise in research and development.
Market Overview
The antacids are medications prepared to neutralize the stomach acid. The Japanese antacid market focused on the production, distribution, and sale of the medications that give relief from symptoms like heartburn, indigestion, and acid reflux. The common ingredients used in the antacid are aluminium hydroxide, magnesium carbonate, and calcium carbonate. This medication is primarily used to treat various gastrointestinal issues. They are available in various forms such as tablets, liquid, and chewable tablets. Japan has a fast lifestyle, which leads to increased consumption of spicy, fatty, and acidic foods, which further leads to stomach acid and heartburn, raising the demand for antacids. The aging population has more chances for digestive issues due to slower digestion and weakened stomach acid, which further surges the demand for acid reflux. The rising demand for natural and organic ingredients is are key trend in this market. The people are becoming health-conscious, and they are seeking products with fewer chemicals, which creates an opportunity for the formulation of antacids by using herbal extracts and probiotics.
Report Coverage
This research report categorizes the market for the Japan antacids market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan antacids market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan antacids market.
Japan Antacids Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 344.8 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 5.44% |
2035 Value Projection: | USD 617.4 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 190 |
Tables, Charts & Figures: | 114 |
Segments covered: | By Type, By End Use COVID-19 Impact Analysis |
Companies covered:: | Takeda Pharmaceutical Company Limited, Hikma Pharmaceuticals PLC, OHTAS ISAN Co., Ltd., Taiko Pharmaceutical, Izumi Yakuhin Kogyou, Matsumoto Pharmaceutical Manufacture Co., Ltd., Kowa Company, Ltd., Other. |
Pitfalls & Challenges: | Covid 19 Impact Challenges, Future, Growth and Analysis |
Get more details on this report -
Driving Factors
The change in lifestyle and dietary habits, especially among young people, fuels the demand for antacid products. The increasing prevalence of various gastrointestinal diseases, such as GERD, peptic ulcers, and dyspepsia, further raises the demand for antacid products. The people are becoming more educated about digestive health, hence more people are taking OTC formulations before consulting healthcare practitioners. The fast lifestyle leads to high stress levels, which further leads to heartburn and acid reflux, which further contributes to the demand for antacid products. The growing trend of health and wellness propels the integration of antacid ingredients in food supplements.
Restraining Factors
The frequent use of antacids leads to long-term side effects and complications like kidney diseases, altered mineral absorption, which deters consumers from frequent use of antacids, which further limits the market expansion. The numerous companies offer various antacid products, which has led to a price war and reduced profit margin for manufacturers.
Market Segmentation
The Japan antacid market share is classified into type and end use.
- The tablet segment held the dominant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan antacid market is segmented by type into tablet, liquid, and others. Among these, the tablet segment held the dominant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the availability of antacids in different flavors, and they are easy to store. Additionally, they can provide an exact dose of medication as compared to other dosage forms.
- The retail pharmacy segment held the largest share in 2024 and is expected to grow at a substantial CAGR during the forecast period.
The Japan antacid market is segmented by end use into retail pharmacy, hospital pharmacy, and online pharmacy. Among these, the retail pharmacy segment held the largest share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This segmental growth is attributed to its ease of access, convenience, and proximity to pharmacy stores.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan antacid market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Takeda Pharmaceutical Company Limited
- Hikma Pharmaceuticals PLC
- OHTAS ISAN Co., Ltd.
- Taiko Pharmaceutical
- Izumi Yakuhin Kogyou
- Matsumoto Pharmaceutical Manufacture Co., Ltd.
- Kowa Company, Ltd.
- Other
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan antacids market based on the below-mentioned segments:
Japan Dried Antacids Market, By Type
- Tablet
- Liquid
- Others
Japan Dried Antacids Market, By End Use
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Need help to buy this report?